Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease.
CONCLUSIONS: Injectable polyvalent pneumococcal vaccination provides significant protection against community-acquired pneumonia, although no evidence indicates that vaccination reduced the risk of confirmed pneumococcal pneumonia, which was a relatively rare event. Vaccination reduced the likelihood of a COPD exacerbation, and moderate-quality evidence suggests the benefits of pneumococcal vaccination in people with COPD. Evidence was insufficient for comparison of different pneumococcal vaccine types.
PMID: 28116747 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Walters JA, Tang JN, Poole P, Wood-Baker R Tags: Cochrane Database Syst Rev Source Type: research
More News: Cardiology | Chronic Obstructive Pulmonary | Databases & Libraries | General Medicine | Healthcare Costs | Heart | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Study | Vaccines